The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients
Status:
Terminated
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
Comparative analysis of the severity of Hand-Foot-Syndrome (HFS) of palms treated with
brimonidine tartrate gel or with standard care Urea 10% containing lotion in cancer patients
receiving antineoplastic therapy to show a preventive effect of cutaneous brimonidine
treatment on severity of HFS symptoms.